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The conundrum of increased burden of end-stage renal disease
in Asians.
Background. Few cohort studies have examined the risk of
end-stage renal disease (ESRD) among Asians compared with
whites and blacks.
Methods. To compare the incidence of ESRD in Asians,
whites, and blacks in Northern California, we examined so-
ciodemographic and clinical data on 299,168 adults who under-
went a screening health checkup at Kaiser Permanente between
1964 and 1985. Incident cases of ESRD were ascertained by
matching patient identifiers with the nationally comprehensive
United States Renal Data System ESRD registry.
Results. Overall, 1346 cases of ESRD occurred during
7,837,310 person-years of follow-up. The age-adjusted rate of
ESRD (per 100,000 person-years) was 14.0 [95% confidence
interval (CI) 10.5–18.5] among Asians, 7.9 (95% CI 6.5–9.5)
among whites, and 43.4 (95% CI 36.6–51.4)] among blacks.
Controlling for age, gender, educational attainment, diabetes,
prior myocardial infarction, serum creatinine, systolic and dias-
tolic blood pressure, proteinuria, hematuria, cigarette smoking,
serum total cholesterol, and body mass index increased the risk
of ESRD in Asians relative to whites from 1.69 to 2.08 (95%
CI 1.61–2.67). By contrast, adjustment for the same covariates
decreased the risk of ESRD in blacks relative to whites from
5.30 to 3.28 (95% CI 2.91–3.69).
Conclusion. Factors contributing to the excess ESRD risk in
Asians relative to whites extend beyond usually considered so-
ciodemographic and comorbidity disparities. Strategies aimed
at examining novel risk factors for kidney disease and efforts to
increase awareness of kidney disease among Asians may reduce
ESRD incidence in this high-risk group.
Asians (which includes Asian and Pacific Islander eth-
nicities) are proportionally the fastest growing race or
ethnic group in the United States. From April 1, 2000 to
July 1, 2003, the Asian population surged by 12.5% to
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13.5 million (5% of the total U.S. population) [1]. The
U.S. Asian population is an ethnically diverse group rep-
resenting different Asian ancestries, socioeconomic back-
grounds, metabolic phenotypes, and access to care [1, 2].
Registry level data from the United States Renal Data
System (USRDS) show that Asians have a 34% higher
age- and gender-adjusted risk of treated end-stage renal
disease (ESRD) compared to whites [3]. In contrast with
extensive literature examining the excess risk of ESRD
in blacks versus whites in the U.S. [4–7], few prospective
studies have assessed the risk of ESRD among Asians
compared with whites [4, 6].
To address these issues, we compared the epidemiol-
ogy of ESRD among Asians, whites, and blacks in a mul-
tiethnic cohort of 299,168 persons receiving care within a
large integrated health care delivery system. We sought
to establish whether Asian race remained an indepen-
dent predictor for ESRD after adjustment for individual
subject-level risk factors.
METHODS
Study population
The study population included a large, multiethnic co-
hort of Kaiser Permanente of Northern California mem-
bers who participated in the Multiphasic Health Testing
Service Program at the Oakland and San Francisco med-
ical centers between 1964 and 1985 [8]. Kaiser Perma-
nente of Northern California is a large, integrated health
care delivery system that currently cares for more than
one third of the insured adult population in the greater
San Francisco Bay Area. Kaiser members are highly
representative of the demographic and clinical aspects
of the surrounding local and state population, with the
exception of both extremes of income [9]. The Multipha-
sic Health Checkup (MHC) was a voluntary health as-
sessment offered at initial and yearly open enrollment
periods [8]. Data were available for 3 MHC periods:
June 1964 to August 1973, September 1973 to December
1977, and January 1978 to March 1985. The MHC periods
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were separately funded phases of screening examinations
that contained common data elements across all peri-
ods and variables unique to each phase. Institutional Re-
view Boards at the collaborating institutions approved
the study.
The analytic sample comprised all individuals who par-
ticipated in the MHC examinations from 1964 to 1985
who were aged 18 years or older and had at least 1 concur-
rent measurement of blood pressure, serum creatinine,
dipstick urinalysis, height, and weight. We excluded those
with baseline serum creatinine concentrations greater
than 10 mg/dL because they were likely to already have
end-stage renal disease. We did not include in our analysis
individuals of other (N = 20,976) and unknown or miss-
ing race (N = 108). The final study population included
299,168 eligible persons.
Assessment of race and covariates
Race was determined based on self-report as “Asian,”
“white,” or “black.” Dipstick urinalysis quantified
protein as negative, trace, 1–2+, and 3–4+. Urine
hemoglobin was quantified as negative, small, moder-
ate, and large. Sitting blood pressure was measured once
based on the acoustic detection of the onset (systolic
point) and disappearance (diastolic point) of Korotkoff
sounds. Blood pressure was categorized according to the
Seventh Joint National Committee (JNC-VII) classifi-
cation as normal (systolic <120 mm Hg and diastolic
<80 mm Hg), prehypertension (systolic 120 to 139 mm
Hg or diastolic 80 to 89 mm Hg), stage 1 hypertension
(systolic 140 to 159 mm Hg or diastolic 90 to 99 mm Hg),
and stage 2 hypertension (systolic ≥160 mm Hg or dias-
tolic ≥100 mm Hg) [10]. Body mass index (kg/m2) was
calculated from measured height and weight. Informa-
tion regarding other relevant covariates (e.g., history of
myocardial infarction) was obtained from self-completed
questionnaires administered within 45 days of blood tests.
Diabetes mellitus was defined as self-report of a physician
diagnosis or random blood glucose >200 mg/dL. Educa-
tional attainment was categorized as high school or less,
some college, and college graduate or higher. Cigarette
smoking status was classified as never, former, and cur-
rent [8]. Medical history data were not available in elec-
tronic format for participants from September 1973 to
December 1977 and, hence, these subjects were classified
as missing those data elements.
Identification of end-stage renal disease
ESRD was defined as receipt of renal transplantation
or maintenance hemodialysis or peritoneal dialysis. We
identified cases of ESRD by matching our cohort against
the nationally comprehensive United States Renal Data
System registry data [3]. Matching was performed blinded
to exposure status using subjects’ social security number,
first and last name, gender, and date of birth. We assessed
ESRD through December 31, 2000, the most recent date
that data were available at the time of study initiation.
We calculated person-time as years elapsed from base-
line (date of checkup) until development of ESRD, death,
or end of follow-up on December 31, 2000, whichever oc-
curred first.
Death ascertainment
Death from any cause was identified using the
California Automated Mortality Linkage Information
System (CAMLIS), which includes all deaths occurring
in the state of California. CAMLIS has shown excellent
sensitivity (97%) and specificity (93%) for vital status
compared with the National Death Index [11].
Statistical analysis
All analyses were based on data collected at the first
eligible checkup for each subject. We compared base-
line characteristics between Asians versus whites and
blacks versus whites using the Student t test for con-
tinuous variables and the chi-square test for categorical
variables. Age-adjusted rates (per 100,000 person-years)
of ESRD were calculated using Poisson regression ad-
justed to median age [12]. The relationship between race
and subsequent risk of ESRD was analyzed using time-
to-event methods. After checking and failing to find a
violation of the proportional hazards assumption, multi-
variable analyses were conducted using Cox proportional
hazards models to calculate adjusted hazard ratios (and
associated 95% confidence limits) as an estimate of the
relative risk for Asians and blacks compared to whites
[13]. We specified a series of Cox regression models that
added potential explanatory variables to the unadjusted
base model. We then specified fully adjusted models to
assess the combined effect of all predictors. Predictors
entered into the final model included age, gender, educa-
tional attainment, diabetes, prior myocardial infarction,
serum creatinine, systolic and diastolic blood pressure,
proteinuria, hematuria, cigarette smoking, serum total
cholesterol, and body mass index. All multivariable mod-
els were adjusted for phase of multiphasic checkup, dur-
ing which the baseline assessment occurred. Variables
included a missing value category when needed.
Because previous literature has suggested that Asians
have a higher incidence of glomerulonephritis [14–16],
we specifically tested for interactions between Asian race
and hematuria and proteinuria using multiplicative in-
teraction terms. Because of potential confounding of
hematuria from menstruation, we performed stratified
analyses by gender. All analyses were performed using
SAS statistical software version 8.2 (Cary, NC, USA).
RESULTS
Overall, we identified 299,168 adults who had 1 or
more outpatient measurement of blood pressure, serum
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Table 1. Baseline characteristics of 299,168 adults stratified by race
White Asian Black
Characteristica (N = 221,686) (N = 17,793) (N = 59,689)
Age, mean (SD) years 39.3 (14.3) 35.7 (12.0) c 35.3 (12.4) c
Age range years 18–95 18–84 18–90
Women N (%) 118,097 (53.3) 9676 (54.4) b 34,291 (57.5)c
Diabetes mellitus N (%) 4,261 (1.9) 334 (1.9) 1620 (2.7)
Education% c c
High school or less 74,570 (33.6) 4653 (26.2) 24,514 (41.1)
Some college 50,950 (23.0) 4028 (22.6) 14,314 (24.0)
College graduate 45,349 (20.5) 4222 (23.7) 5209 (8.7)
Unknown 50,817 (22.9) 4890 (27.5) 15,652 (26.2)
Cigarette smoking history N (%) c c
Never 68,912 (31.1) 8405 (47.2) 17,772 (29.8)
Former 33,865 (15.3) 1316 (7.4) 5894 (9.9)
Current 63,191 (28.5) 3043 (17.1) 19,886 (33.3)
Unknown 55,717 (25.1) 5029 (28.3) 16,137 (27.0)
Prior myocardial infarction N (%) c c
No 173,117 (78.1) 13,294 (74.7) 44,670 (74.8)
Yes 4,864 (2.2) 213 (1.2) 1256 (2.1)
Unknown 43,705 (19.7) 4286 (24.1) 13,763 (23.1)
Systolic BP, mean (SD) mm Hg 129 (20) 123 (19) c 131 (21) c
Diastolic BP, mean (SD) mm Hg 76 (13) 75 (12) c 78 (14) c
Serum cholesterol, mean (SD) mg/dL 215 (45) 209 (42) c 208 (45) c
Serum creatinine, mean (SD) mg/dL 0.95 (0.24) 0.89 (0.23) c 0.97 (0.25) c
Body mass index, mean (SD) kg/m2 24.4 (4.1) 22.4 (3.2) c 25.7 (5.1) c
Urine protein N (%) c c
Negative 213,215 (96.2) 17,230 (96.8) 56,566 (94.8)
Trace 4606 (2.1) 274 (1.5) 1749 (2.9)
1–2+ 3464 (1.6) 253 (1.4) 1169 (2.0)
3–4+ 401 (0.2) 36 (0.2) 205 (0.3)
Urine hemoglobin N (%) c c
Negative 212,452 (95.8) 16,579 (93.2) 56,180 (94.1)
Small 6558 (3.0) 764 (4.3) 2230 (3.7)
Moderate 1735 (0.8) 257 (1.4) 740 (1.2)
Large 941 (0.4) 193 (1.1) 539 (0.9)
aDue to rounding, percentages may not total 100.
bP < 0.01.
cP < 0.001.
creatinine concentration, and dipstick urinalysis. This
study population included 17,793 Asians (5%), 221,686
whites (75%) and 59,689 blacks (20%) who were collec-
tively followed for 7,837,310 person-years (mean of 26.2
± 7.1 years per person). At baseline, Asians were signifi-
cantly younger, more likely to have finished high school,
and less likely to have ever smoked cigarettes compared
to whites. Additionally, Asians had significantly lower
baseline mean systolic and diastolic blood pressures, and
lower mean serum total cholesterol and creatinine con-
centrations relative to whites, but there was no significant
difference in prevalent diabetes mellitus (Table 1). The
baseline prevalence of hematuria was significantly higher
in Asian men and women compared to their white coun-
terparts (Asians vs. whites: 2.0% vs. 1.3% in men and
10.8% vs. 6.7% in women; P < 0.001, respectively).
In comparison, blacks had higher baseline mean sys-
tolic and diastolic blood pressures, and were more likely
to have diabetes mellitus and proteinuria compared with
whites (Table 1).
There were a total of 1346 cases of ESRD (69 in
Asians, 583 in whites, and 694 in blacks) identified during
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Fig. 1. Age-adjusted rates of end-stage renal disease among 299,168
adults stratified by race.
7,837,310 person-years of observation. The age-adjusted
rate of ESRD (per 100,000 person-years) was 14.0 (95%
CI 10.5–18.5) among Asians, 7.9 (95% CI 6.5–9.5) among
whites, and 43.4 (95% CI 36.6–51.4) among blacks (Fig. 1).
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Table 2. Characteristics of 1346 screened adults who developed end-stage renal disease stratified by race
White Asian Black
Characteristica (N = 583) (N = 69) (N = 694)
Age, mean (SD) years 44.8 (11.3) 43.3 (10.0) 40.5 (11.6) d
Age range years 18–74 25–68 18–77
Duration to ESRD, mean (SD) years 21.7 (7.7) 21.1 (7.6) 20.4 (7.7) c
Women N (%) 211 (36.2) 23 (33.3) 304 (43.8) c
Diabetes mellitus N (%) 73 (12.5) 10 (14.5) 122 (17.6) b
Systolic BP, mean (SD) mm Hg 140 (21) 138 (20) 143 (24) b
Diastolic BP, mean (SD) mm Hg 84 (13) 84 (11) 87 (15) d
Serum cholesterol, mean (SD) mg/dL 231 (47) 229 (48) 219 (49)d
Serum creatinine, mean (SD) mg/dL 1.12 (0.57) 1.14 (0.64) 1.10 (0.38)
Body mass index, mean (SD) kg/m2 27.8 (5.5) 26.1 (4.3) c 29.2 (5.7) d
Urine protein N (%)
Negative 484 (83.0) 52 (75.4) 568 (81.8)
Trace 30 (5.1) 6 (8.7) 38 (5.5)
1–2+ 50 (8.6) 8 (11.6) 59 (8.5)
3–4+ 19 (3.3) 3 (4.3) 29 (4.2)
Urine hemoglobin N (%)
Negative 547 (93.8) 61 (88.4) 657 (94.7)
Small 20 (3.4) 5 (7.2) 23 (3.3)
Moderate 10 (1.7) 2 (2.9) 5 (0.7)
Large 6 (1.0) 1 (1.5) 9 (1.3)
aDue to rounding, percentages may not total 100.
bP < 0.05.
cP < 0.01.
dP < 0.001.
Table 3. Multivariable association of the risk for end-stage renal disease in Asians and blacks compared with whites
Asian versus white Black versus white
Adjusted Hazard Ratio Adjusted Hazard Ratio
Model (95% Confidence Interval) (95% Confidence Interval)
Unadjusted 1.69 (1.32–2.17) 5.30 (4.75–5.92)
Adjustment for age, gender, education, and exam phase 1.61 (1.25–2.07) 5.14 (4.58–5.76)
Additional adjustment for diabetes, prior myocardial infarction, serum creatinine,
systolic and diastolic blood pressure, proteinuria, and hematuria
1.68 (1.31–2.16) 3.69 (3.28–4.15)
Additional adjustment for cigarette smoking, serum total cholesterol, and body
mass index
2.08 (1.61–2.67) 3.28 (2.91–3.69)
Baseline characteristics of patients in each racial group
who ultimately developed ESRD are shown in Table 2.
Adjustment for age, gender, educational attainment,
and multiphasic checkup phase slightly decreased the
ESRD risk in Asians and blacks relative to whites
(Table 3). Further adjustment for baseline clinical charac-
teristics (diabetes, prior myocardial infarction, serum cre-
atinine, systolic and diastolic blood pressure, proteinuria,
and hematuria) did not notably alter the risk of ESRD
in Asians (from 1.61 to 1.68), but decreased the risk of
ESRD in blacks (from 5.14 to 3.69) relative to whites.
Additional adjustment for “behaviorally modifiable” fac-
tors (cigarette smoking, serum total cholesterol, and body
mass index) resulted in a substantial increase in the risk
of ESRD in Asians (from 1.68 to 2.08) relative to whites.
In contrast, adjustment for these same factors further at-
tenuated the risk of ESRD in blacks (from 3.69 to 3.28)
relative to whites (Table 3).
As expected, an independent, graded association be-
tween categories of proteinuria and risk of ESRD was
observed [17]. However, we found no multivariable as-
sociation between categories of hematuria and the risk
of ESRD in either men or women (although a trend may
be present in men). Being Asian was an independent risk
factor for ESRD in both men and women (adjusted haz-
ard ratio 2.07 in men and 2.03 in women, respectively).
We found no significant interactions between race and
either proteinuria or hematuria in men or women.
DISCUSSION
Asians are proportionately the fastest growing race or
ethnic group in the U.S. and the largest race or ethnic
group worldwide. Yet, relatively little is known about the
epidemiology of ESRD in the U.S. Asian population. The
most recent registry data from the USRDS indicate that
Asians have higher age- and gender-adjusted incidence
rates of ESRD relative to whites [344 cases per million
population (pmp) in Asians vs. 256 pmp in whites] [3].
Although an extensive literature exists examining the ex-
cess risk of ESRD in another racial minority (i.e., blacks)
[4–7], few prospective studies have assessed the risk of
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ESRD among Asians compared with whites and blacks
after adjusting for individual subject-level risk factors [6].
In a large, multiethnic cohort with equal access to
health care, we found that after accounting for many
of the previously described risk factors for ESRD, such
as age, diabetes, baseline blood pressure, and protein-
uria, Asian race remained a strong, independent risk fac-
tor for ESRD. In models adjusted for sociodemographic
and clinical data, the risk of ESRD in Asians was more
than 2-fold higher compared with whites. The higher risk
of ESRD associated with Asian race was observed in
both men and women, and in contrast to that of blacks,
increased with adjustment for many of the usually con-
sidered risk factors which may confound observed asso-
ciations between race/ethnicity and risk of ESRD.
Our study extends knowledge of the link between
Asian race and ESRD. Previously, Klag et al observed
higher age-adjusted ESRD rates among Asians relative
to whites in a large cohort of men (N = 332,544) screened
for the Multiple Risk Factor Intervention Trial (MRFIT)
and followed for a mean of 16 years [4]. That study,
however, included no women. Moreover, because Asians
(N = 4190) were not the focus of their investigation, and
relatively few cases of ESRD occurred among Asians, no
multivariable adjustment was performed that included
Asian race. In contrast, we adjusted for extensive base-
line covariates that included indicators of baseline renal
disease in a larger population of Asians (N = 17,793) who
were followed for a longer period of time (mean follow-
up, 26 years). Karter et al showed in a large, prospec-
tive cohort (N = 62,432) of patients with diabetes that
despite uniform medical care access, Asians had a 1.85-
fold higher adjusted risk (95% CI 1.40–2.43; P < 0.001)
of ESRD compared with whites [6]. Although strength-
ened by comprehensive baseline clinical data (includ-
ing measures of the severity of diabetes and hyperten-
sion), these observations by Karter et al were limited
to only patients with diabetes mellitus. Iseki et al iden-
tified 420 cases of ESRD after a mean follow-up of 17
years among 106,177 Okinawan adults who participated
in a community-based mass screening program for blood
pressure and dipstick urinalysis [17]. Compared to Iseki
et al, one inherent advantage of our study cohort was
the ability to compare ESRD incidence among Asians,
whites, and blacks from the same geographic location.
We also adjusted for more extensive baseline sociode-
mographic and clinical data, and linked patient identifiers
to state death records to ascertain complete vital status
information.
Explanatory factors for the excess burden
of ESRD in Asians
As witnessed by the divergent directions of our risk es-
timates after adjustment, the origins of the discrepancy in
ESRD risk between Asians and whites does not appear
to be explained by the socioeconomic and comorbidity
disparities paradigm present in the black versus white
model. In fact, adjustment for baseline sociodemographic
characteristics, clinical comorbidities, and behaviorally
modifiable risk factors not only failed to explain but fur-
ther increased the risk estimate for ESRD in Asians com-
pared to whites. The inability of traditional risk factors to
explain the increased risk of ESRD among Asians sug-
gests a potential role for nontraditional risk factors.
The role of glomerulonephritis
Studies in Asians often cite genetic susceptibility to
glomerular diseases as an important risk factor for ESRD
[6, 16]. Biopsy series from regions in the U.S. with large
Asian populations indicate a higher prevalence of IgA
nephropathy among Asians [18, 19]. Hence, it is note-
worthy that we observed a slightly greater prevalence of
baseline hematuria among Asians compared to whites.
Iseki et al found hematuria to be a significant independent
risk factor for ESRD among men, but not among women
in their study of Okinawans, with the latter observation
possibly being attributable to menstrual contamination
[17]. In our study, Asian race remained an independent
risk factor after we adjusted for hematuria. Furthermore,
we found no significant interactions between Asian race
and hematuria.
Therefore, our data do not lend support for the hypoth-
esis that increased prevalence of glomerulonephritis ex-
plains the observed 2-fold higher adjusted risk of ESRD
in Asians relative to whites.
The potential role of traditional Asian herbal
and other remedies
Cultural factors may also play a role in the in-
creased risk of ESRD in Asians. Prior studies report that
Asian patients utilize “non-Western medicine” pharma-
cies and practitioners with greater frequency compared
with whites [20, 21]. Among Asians completing health
surveys in Oakland and San Francisco Chinatowns, over
45% affirmed at least 1 visit to a practitioner of traditional
Chinese medicine within the previous 12 months [20].
It is possible that some Asian herbal and other reme-
dies contain nephrotoxic compounds that are not well
defined. The best known example of nephrotoxicity
from (mis)use of Chinese herbs is renal failure due to
aristolochic acid ingestion [22, 23]. Nonsteroidal anti-
inflammatory agents, diuretics, and heavy metals are
also common adulterants contained in tested Chinese
medicine samples [24, 25]. With the increasing popular-
ity of such products among non-Asian consumers, these
observations raise concerns regarding the potential mag-
nitude of unrecognized cases of nephropathy due to
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ingestion of these and other less well-defined nephrotoxic
agents [26, 27].
Strengths and limitations
Our study was strengthened by the large, diverse sam-
ple of screened adults with initial uniform medical care
access and comprehensive, longitudinal follow-up for
ESRD. In addition, unlike USRDS registry data, we used
self-reported race and were able to control for important
clinical and demographic factors at study entry. It is inter-
esting to note that the relative risk of ESRD for Asians
compared with whites in our study increased after adjust-
ment for the typically considered risk factors for ESRD,
as identification of such risk factors have come primarily
from studies of black versus white patients.
Our study also had several limitations. Although our
study population started with uniform medical insurance,
differential loss of insurance coverage and/or treatments
received over the time course to ESRD could have con-
founded our results. We only had a single ascertainment
of exposures at study entry and information on diet,
physical activity, and other exposures were not available.
While the methodology for measuring serum creatinine
likely changed over the 2 decades during which Multi-
phasic Health Checkups were performed, these changes
would affect the different racial groups similarly. We also
did not have data on the longitudinal evolution of renal
function as patients progressed toward ESRD, nor did we
have access to biospecimens to evaluate for potential ge-
netic or physiologic factors contributing to the observed
racial differences in risk for ESRD. Despite the potential
advantages of a regional cohort which controls, at least in
part, for unidentified environmental factors, our cohort
may not reflect the environment or genetic makeup of
the U.S. Asian population as a whole. Although Asians
in San Francisco and the greater Bay Area are ethnically
diverse (e.g., Filipino, Chinese, Japanese, Asian Indian,
etc.), due to the rarity of events, we were unable to evalu-
ate the risk of ESRD for individual ethnicities. Hence, our
aggregate estimates may conceal potential differences in
risk factors and associated outcomes within the Asian
population [28–31].
CONCLUSION
Our results suggest that factors contributing to the
excess ESRD risk in Asians relative to whites extend
beyond the usually considered sociodemographic and co-
morbidity disparities that account for a significant pro-
portion of the excess ESRD risk observed in blacks.
Strategies aimed at examining novel risk factors for kid-
ney disease and efforts to increase awareness of kidney
disease among Asians may reduce ESRD incidence in
this high-risk group.
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